Literature DB >> 11209789

Major histocompatibility complex variation in the Arabian oryx.

P W Hedrick1, K M Parker, G A Gutiérrez-Espeleta, A Rattink, K Lievers.   

Abstract

In the 1960s, the Arabian oryx was one of the most endangered species in the world, extinct in the wild and surviving in only a few captive herds. The present day population of over 2000 descends from a small number of founders and may have restricted genetic variation for important adaptive genes. We have examined the amount of genetic variation for a class II gene in the major histocompatibility complex thought to be the most important genetic basis for pathogen resistance in vertebrates. We found three very divergent alleles, which on average, differed by 24 nucleotides and 15 amino acids in the 236-bp fragment we examined. Using single-strand conformation polymorphism, we found that in a sample of 57 animals, the alleles were in Hardy-Weinberg proportions, although one allele was found only in four heterozygous individuals. The average heterozygosity for the 22 amino acid positions involved in antigen binding was 0.165, three times as high as that for the 56 amino acids not involved with antigen binding. Because the three alleles have such divergent sequences, it is likely that they may recognize peptides from quite different pathogens. As a result, maintenance of these variants should be considered as a goal in the captive breeding program of the Arabian oryx.

Entities:  

Mesh:

Year:  2000        PMID: 11209789     DOI: 10.1111/j.0014-3820.2000.tb01256.x

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  30 in total

1.  Evolution of MHC class II E beta diversity within the genus Peromyscus.

Authors:  Adam D Richman; L Gerardo Herrera; Deanna Nash
Journal:  Genetics       Date:  2003-05       Impact factor: 4.562

2.  A temporal analysis shows major histocompatibility complex loci in the Scandinavian wolf population are consistent with neutral evolution.

Authors:  J M Seddon; H Ellegren
Journal:  Proc Biol Sci       Date:  2004-11-07       Impact factor: 5.349

3.  Duplication, balancing selection and trans-species evolution explain the high levels of polymorphism of the DQA MHC class II gene in voles (Arvicolinae).

Authors:  J Bryja; M Galan; N Charbonnel; J F Cosson
Journal:  Immunogenetics       Date:  2006-02-09       Impact factor: 2.846

Review 4.  Characterising functionally important and ecologically meaningful genetic diversity using a candidate gene approach.

Authors:  Stuart B Piertney; Lucy M I Webster
Journal:  Genetica       Date:  2008-09-21       Impact factor: 1.082

5.  Sequence diversity of MHC class-II DRB gene in gazelles (Gazella subgutturosa) raised in Sanliurfa of Turkey.

Authors:  Faruk Bozkaya; Sükrü Gürler
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

6.  MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer.

Authors:  Hannah V Siddle; Jolanta Marzec; Yuanyuan Cheng; Menna Jones; Katherine Belov
Journal:  Proc Biol Sci       Date:  2010-03-10       Impact factor: 5.349

7.  Are large wattles related to particular MHC genotypes in the male pheasant?

Authors:  Mariella Baratti; Martina Ammannati; Claudia Magnelli; Alessandro Massolo; Francesco Dessì-Fulgheri
Journal:  Genetica       Date:  2010-02-10       Impact factor: 1.082

8.  Recombination and the origin of sequence diversity in the DRB MHC class II locus in chamois (Rupicapra spp.).

Authors:  Helmut Schaschl; Franz Suchentrunk; Sabine Hammer; Simon J Goodman
Journal:  Immunogenetics       Date:  2005-03-09       Impact factor: 2.846

9.  Allelic combinations of promoter and exon 2 in DQB1 in dogs and wolves.

Authors:  Karin T Berggren; Jennifer M Seddon
Journal:  J Mol Evol       Date:  2008-06-27       Impact factor: 2.395

10.  MHC class II variation in the endangered European mink Mustela lutreola (L. 1761)--consequences for species conservation.

Authors:  L Becker; C Nieberg; K Jahreis; E Peters
Journal:  Immunogenetics       Date:  2009-03-05       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.